{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:40:34Z","timestamp":1778647234464,"version":"3.51.4"},"publisher-location":"Cham","reference-count":59,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319777351","type":"print"},{"value":"9783319777368","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-77736-8_7","type":"book-chapter","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T11:12:00Z","timestamp":1530011520000},"page":"95-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non-Hodgkin Lymphoma Metabolism"],"prefix":"10.1007","author":[{"given":"Brian James","family":"Kirsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"9844","key":"7_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland, K. R., Armitage, J. O., & Hancock, B. W. (2012). Non-Hodgkin lymphoma. Lancet, 380(9844), 848\u2013857.","journal-title":"Lancet"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/B978-0-323-24098-7.00077-0","volume-title":"Clinical radiation oncology","author":"KM Winkfield","year":"2016","unstructured":"Winkfield, K. M., Tsang, R. W., & Gospodarowicz, M. K. (2016). Non-Hodgkin\u2019s lymphoma. In Clinical radiation oncology (4th ed., pp. 1524\u20131546.e7). Philadelphia: Elsevier.","edition":"4"},{"issue":"1","key":"7_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","volume":"31","author":"RH Advani","year":"2013","unstructured":"Advani, R. H., et al. (2013). Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. Journal of Clinical Oncology, 31(1), 88\u201394.","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"7_CR4","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel, R., Sehn, L. H., & Gascoyne, R. D. (2012). Pathogenesis of follicular lymphoma. The Journal of Clinical Investigation, 122(10), 3424\u20133431.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"7_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11912-012-0258-4","volume":"14","author":"E Wong","year":"2012","unstructured":"Wong, E., & Dickinson, M. (2012). Transformation in follicular lymphoma: Biology, prognosis, and therapeutic options. Current Oncology Reports, 14(5), 424\u2013432.","journal-title":"Current Oncology Reports"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska, A., et al. (2014). Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood, 123, 1681.","journal-title":"Blood"},{"issue":"2","key":"7_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun, J., et al. (2014). Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genetics, 46(2), 176\u2013181.","journal-title":"Nature Genetics"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1084\/jem.20132120","volume":"211","author":"E Oricchio","year":"2014","unstructured":"Oricchio, E., & Wendel, H. G. (2014). Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. Journal of Experimental Medicine, 211, 1379.","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"7_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.immuni.2015.09.001","volume":"43","author":"SK Biswas","year":"2015","unstructured":"Biswas, S. K. (2015). Metabolic reprogramming of immune cells in cancer progression. Immunity, 43(3), 435\u2013449.","journal-title":"Immunity"},{"issue":"1","key":"7_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1148\/radiology.190.1.8259386","volume":"190","author":"JS Newman","year":"1994","unstructured":"Newman, J. S., et al. (1994). Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT. Radiology, 190(1), 111\u2013116.","journal-title":"Radiology"},{"issue":"3","key":"7_CR11","first-page":"325","volume":"33","author":"J Okada","year":"1992","unstructured":"Okada, J., et al. (1992). Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity. Journal of Nuclear Medicine, 33(3), 325\u2013329.","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"7_CR12","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.18632\/oncotarget.6315","volume":"7","author":"L Mediani","year":"2016","unstructured":"Mediani, L., et al. (2016). Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K\/Akt\/mTOR signaling. Oncotarget, 7(5), 5521\u20135537.","journal-title":"Oncotarget"},{"issue":"2","key":"7_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12291-015-0511-3","volume":"31","author":"C Yadav","year":"2016","unstructured":"Yadav, C., et al. (2016). Serum lactate dehydrogenase in non-Hodgkin\u2019s lymphoma: A prognostic indicator. Indian Journal of Clinical Biochemistry, 31(2), 240\u2013242.","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"4","key":"7_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000206395","volume":"72","author":"G Fasola","year":"1984","unstructured":"Fasola, G., et al. (1984). Serum LDH concentration in non-Hodgkin\u2019s lymphomas. Relationship to histologic type, tumor mass, and presentation features. Acta Haematologica, 72(4), 231\u2013238.","journal-title":"Acta Haematologica"},{"issue":"2","key":"7_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/bjc.1989.57","volume":"59","author":"RA Cowan","year":"1989","unstructured":"Cowan, R. A., et al. (1989). Prognostic factors in high and intermediate grade non-Hodgkin\u2019s lymphoma. British Journal of Cancer, 59(2), 276\u2013282.","journal-title":"British Journal of Cancer"},{"issue":"1","key":"7_CR16","first-page":"25","volume":"5","author":"WM Claudino","year":"2015","unstructured":"Claudino, W. M., et al. (2015). Type B lactic acidosis: A rare but life threatening hematologic emergency. A case illustration and brief review. American Journal of Blood Research, 5(1), 25\u201329.","journal-title":"American Journal of Blood Research"},{"issue":"3","key":"7_CR17","first-page":"120","volume":"69","author":"R Groot de","year":"2011","unstructured":"de Groot, R., et al. (2011). Type B lactic acidosis in solid malignancies. The Netherlands Journal of Medicine, 69(3), 120\u2013123.","journal-title":"The Netherlands Journal of Medicine"},{"issue":"4","key":"7_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0011-5029(89)90021-7","volume":"35","author":"BA Mizock","year":"1989","unstructured":"Mizock, B. A. (1989). Lactic acidosis. Disease-a-Month, 35(4), 233\u2013300.","journal-title":"Disease-a-Month"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1100\/tsw.2011.125","volume":"11","author":"JP Ruiz","year":"2011","unstructured":"Ruiz, J. P., Singh, A. K., & Hart, P. (2011). Type B lactic acidosis secondary to malignancy: Case report, review of published cases, insights into pathogenesis, and prospects for therapy. Scientific World Journal, 11, 1316\u20131324.","journal-title":"Scientific World Journal"},{"issue":"5","key":"7_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF02849863","volume":"22","author":"E Dogan","year":"2005","unstructured":"Dogan, E., et al. (2005). Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin\u2019s lymphoma: Case report. Advances in Therapy, 22(5), 443\u2013446.","journal-title":"Advances in Therapy"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"534561","DOI":"10.1155\/2009\/534561","volume":"2009","author":"FH Chan","year":"2009","unstructured":"Chan, F. H., Carl, D., & Lyckholm, L. J. (2009). Severe lactic acidosis in a patient with B-cell lymphoma: A case report and review of the literature. Case Reports in Medicine, 2009, 534561.","journal-title":"Case Reports in Medicine"},{"issue":"10","key":"7_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","volume":"88","author":"LW Andersen","year":"2013","unstructured":"Andersen, L. W., et al. (2013). Etiology and therapeutic approach to elevated lactate levels. Mayo Clinic Proceedings, 88(10), 1127\u20131140.","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"7_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.ajkd.2013.03.036","volume":"62","author":"P Sia","year":"2013","unstructured":"Sia, P., Plumb, T. J., & Fillaus, J. A. (2013). Type B lactic acidosis associated with multiple myeloma. American Journal of Kidney Diseases, 62(3), 633\u2013637.","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"7_CR24","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J., & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2(5), e1600200.","journal-title":"Science Advances"},{"issue":"10","key":"7_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine, Z. E., et al. (2015). MYC, metabolism, and cancer. Cancer Discovery, 5(10), 1024\u20131039.","journal-title":"Cancer Discovery"},{"issue":"2","key":"7_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M., & Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell, 149(2), 274\u2013293.","journal-title":"Cell"},{"issue":"4","key":"7_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/genes8040115","volume":"8","author":"P Korac","year":"2017","unstructured":"Korac, P., et al. (2017). Role of MYC in B cell lymphomagenesis. Genes (Basel), 8(4), 115.","journal-title":"Genes (Basel)"},{"issue":"5","key":"7_CR28","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le, A., et al. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences of the United States of America, 107(5), 2037\u20132042.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"7_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1158\/0008-5472.CAN-13-2034","volume":"74","author":"JR Doherty","year":"2014","unstructured":"Doherty, J. R., et al. (2014). Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Research, 74(3), 908\u2013920.","journal-title":"Cancer Research"},{"issue":"2","key":"7_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S., & Mak, T. W. (2011). Regulation of cancer cell metabolism. Nature Reviews Cancer, 11(2), 85\u201395.","journal-title":"Nature Reviews Cancer"},{"issue":"14","key":"7_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/onc.2016.360","volume":"36","author":"TQ Tran","year":"2017","unstructured":"Tran, T. Q., et al. (2017). Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction. Oncogene, 36(14), 1991\u20132001.","journal-title":"Oncogene"},{"issue":"29","key":"7_CR32","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1205995109","volume":"109","author":"AP Bhatt","year":"2012","unstructured":"Bhatt, A. P., et al. (2012). Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 109(29), 11818\u201311823.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"7_CR33","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1182\/blood-2009-10-251082","volume":"115","author":"AP Bhatt","year":"2010","unstructured":"Bhatt, A. P., et al. (2010). Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K\/Akt\/mTOR-addicted lymphomas. Blood, 115(22), 4455\u20134463.","journal-title":"Blood"},{"issue":"10","key":"7_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.bcp.2006.08.009","volume":"72","author":"AC Faber","year":"2006","unstructured":"Faber, A. C., et al. (2006). Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochemical Pharmacology, 72(10), 1246\u20131256.","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"7_CR35","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","volume":"109","author":"SH Sin","year":"2007","unstructured":"Sin, S. H., et al. (2007). Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood, 109(5), 2165\u20132173.","journal-title":"Blood"},{"issue":"7400","key":"7_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon, S. M., Chandel, N. S., & Hay, N. (2012). AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature, 485(7400), 661\u2013665.","journal-title":"Nature"},{"issue":"4","key":"7_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P., et al. (2012). Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell, 22(4), 547\u2013560.","journal-title":"Cancer Cell"},{"issue":"2","key":"7_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","volume":"52","author":"RM Young","year":"2015","unstructured":"Young, R. M., et al. (2015). B-cell receptor signaling in diffuse large B-cell lymphoma. Seminars in Hematology, 52(2), 77\u201385.","journal-title":"Seminars in Hematology"},{"issue":"8","key":"7_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2016-10-747303","volume":"130","author":"O Havranek","year":"2017","unstructured":"Havranek, O., et al. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood, 130(8), 995\u20131006.","journal-title":"Blood"},{"issue":"1","key":"7_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn, U. E., et al. (2017). Cancer metabolism: A therapeutic perspective. Nature Reviews Clinical Oncology, 14(1), 11\u201331.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"5","key":"7_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nrclinonc.2014.51","volume":"11","author":"PM Wilson","year":"2014","unstructured":"Wilson, P. M., et al. (2014). Standing the test of time: Targeting thymidylate biosynthesis in cancer therapy. Nature Reviews Clinical Oncology, 11(5), 282\u2013298.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"3","key":"7_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","volume":"26","author":"M Visentin","year":"2012","unstructured":"Visentin, M., Zhao, R., & Goldman, I. D. (2012). The antifolates. Hematology\/Oncology Clinics of North America, 26(3), 629\u2013648. ix.","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"5","key":"7_CR43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cell.2014.03.052","volume":"157","author":"JT Cunningham","year":"2014","unstructured":"Cunningham, J. T., et al. (2014). Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell, 157(5), 1088\u20131103.","journal-title":"Cell"},{"issue":"2","key":"7_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K Duvel","year":"2010","unstructured":"Duvel, K., et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell, 39(2), 171\u2013183.","journal-title":"Molecular Cell"},{"issue":"3","key":"7_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0899-9007(99)00266-X","volume":"16","author":"FP Kuhajda","year":"2000","unstructured":"Kuhajda, F. P. (2000). Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition, 16(3), 202\u2013208.","journal-title":"Nutrition"},{"issue":"1","key":"7_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2184.2007.00498.x","volume":"41","author":"A Vazquez-Martin","year":"2008","unstructured":"Vazquez-Martin, A., et al. (2008). Overexpression of fatty acid synthase gene activates HER1\/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Proliferation, 41(1), 59\u201385.","journal-title":"Cell Proliferation"},{"issue":"4","key":"7_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2217\/fon.10.11","volume":"6","author":"R Flavin","year":"2010","unstructured":"Flavin, R., et al. (2010). Fatty acid synthase as a potential therapeutic target in cancer. Future Oncology, 6(4), 551\u2013562.","journal-title":"Future Oncology"},{"issue":"10","key":"7_CR48","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/leu.2009.117","volume":"23","author":"P Gasperini","year":"2009","unstructured":"Gasperini, P., & Tosato, G. (2009). Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia, 23(10), 1867\u20131874.","journal-title":"Leukemia"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fonc.2016.00135","volume":"6","author":"AA Shestov","year":"2016","unstructured":"Shestov, A. A., et al. (2016). (13)C MRS and LC-MS flux analysis of tumor intermediary metabolism. Frontiers in Oncology, 6, 135.","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"7_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","volume":"70","author":"CV Dang","year":"2010","unstructured":"Dang, C. V. (2010). Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Research, 70(3), 859\u2013862.","journal-title":"Cancer Research"},{"issue":"3","key":"7_CR51","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1371\/journal.pone.0001798","volume":"3","author":"J Kim","year":"2008","unstructured":"Kim, J., Lee, J. H., & Iyer, V. R. (2008). Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One, 3(3), e1798.","journal-title":"PLoS One"},{"issue":"21","key":"7_CR52","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"JW Kim","year":"2007","unstructured":"Kim, J. W., et al. (2007). Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Molecular and Cellular Biology, 27(21), 7381\u20137393.","journal-title":"Molecular and Cellular Biology"},{"issue":"14","key":"7_CR53","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","volume":"25","author":"F Li","year":"2005","unstructured":"Li, F., et al. (2005). Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Molecular and Cellular Biology, 25(14), 6225\u20136234.","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"7_CR54","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cmet.2011.06.011","volume":"14","author":"CD Folmes","year":"2011","unstructured":"Folmes, C. D., et al. (2011). Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism, 14(2), 264\u2013271.","journal-title":"Cell Metabolism"},{"issue":"1","key":"7_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le, A., et al. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metabolism, 15(1), 110\u2013121.","journal-title":"Cell Metabolism"},{"issue":"20","key":"7_CR56","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"DM Miller","year":"2012","unstructured":"Miller, D. M., et al. (2012). c-Myc and cancer metabolism. Clinical Cancer Research, 18(20), 5546\u20135553.","journal-title":"Clinical Cancer Research"},{"issue":"23","key":"7_CR57","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1073\/pnas.1203244109","volume":"109","author":"W Liu","year":"2012","unstructured":"Liu, W., et al. (2012). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proceedings of the National Academy of Sciences of the United States of America, 109(23), 8983\u20138988.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"7_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout, J. A., Patel, S. A., & Simon, M. C. (2008). The impact of O2 availability on human cancer. Nature Reviews Cancer, 8(12), 967\u2013975.","journal-title":"Nature Reviews Cancer"},{"issue":"12","key":"7_CR59","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.exphem.2010.08.007","volume":"38","author":"Q Qiao","year":"2010","unstructured":"Qiao, Q., et al. (2010). NF-kappaB mediates aberrant activation of HIF-1 in malignant lymphoma. Experimental Hematology, 38(12), 1199\u20131208.","journal-title":"Experimental Hematology"}],"container-title":["Advances in Experimental Medicine and Biology","The Heterogeneity of Cancer Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-77736-8_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T09:28:08Z","timestamp":1530782888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-77736-8_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319777351","9783319777368"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-77736-8_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}